Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

or expectations of profit attributable to shareholders; anticipated provisions or write-downs, economic profit, dividends, capital structure or any other financial items or ratios; statements of plans, objectives or goals of Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements about the future trends in interest rates, liquidity, foreign exchange rates, stock market levels and demographic trends and any impact that those matters may have on Elan, the Elan Group, RP Management or Royalty Pharma following the Increased Offer; statements concerning any future Irish, US or other economic environment or performance; statements about strategic goals, competition, regulation, regulatory approvals, dispositions and consolidation or technological or regulatory developments; and statements of assumptions underlying such statements.

Forward looking statements only speak as of the date on which they are made, and the events discussed in this announcement may not occur. Subject to compliance with applicable law and regulation, Royalty Pharma is not under any obligation to update publicly or revise forward looking statements, whether as a result of new information, future events or otherwise.

Additional Information

This announcement is not a substitute for the Revised Offer Document and the Revised Acceptance Documents or any other document that Royalty Pharma has filed and may file with the Securities and Exchange Commission ("SEC") (including the Original Offer Document) in connection with the Offer.  ELAN STOCKHOLDERS ARE URGED TO READ ANY SUCH DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE INCREASED OFFER.  Any such documents will be available free of charge through the website maintained by the SEC at www.sec.gov or by directing a request to any of the persons listed above.

The Offer is and will be m
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 This report analyzes ... the following Product Segments: Devices, and Medication. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates and forecasts ... seven-year historic analysis is provided for these markets. Market data ...
(Date:9/16/2014)... 16, 2014 Adaptive Biotechnologies, a clinical stage ... profile the adaptive immune system, is pleased to announce ... Commercial Officer (CCO). The addition of Brain to the ... from leading global healthcare companies, including Dean Schorno ... from Genomic Health and Sean Nolan (CTO) ...
(Date:9/16/2014)... Sept. 16, 2014 EHE International, the recognized leader ... physician network, today announced that David Abrams M.D . ... an EHE-certified preventive care center. Through David Abrams M.D ... region now have greater access to EHE,s preventive care programs ... is proud to add Dr. Abrams M.D. to its growing ...
Breaking Medicine Technology:Global Foot Care Products Industry 2Global Foot Care Products Industry 3Global Foot Care Products Industry 4Global Foot Care Products Industry 5Global Foot Care Products Industry 6Global Foot Care Products Industry 7Global Foot Care Products Industry 8Global Foot Care Products Industry 9Global Foot Care Products Industry 10Global Foot Care Products Industry 11Global Foot Care Products Industry 12Global Foot Care Products Industry 13Global Foot Care Products Industry 14Global Foot Care Products Industry 15Global Foot Care Products Industry 16Global Foot Care Products Industry 17Global Foot Care Products Industry 18Global Foot Care Products Industry 19Global Foot Care Products Industry 20Global Foot Care Products Industry 21Global Foot Care Products Industry 22Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3EHE International Certifies David Abrams M.D. as Its Newest Partner 2
... June 28, 2010 , , ... - Results of First Exposure of Type I Diabetes Patients to Oramed,s Oral,Insulin and of ... , , ... the 2010 Scientific Sessions of the,American Diabetes Association currently being held in Orlando, Florida ...
... Bayer HealthCare Pharmaceuticals today launched FactorTrack™, the first customizable mobile ... and interactive mobile application that helps make it easier to track ... , , ... and locations of bleeds.  It allows people with hemophilia A to ...
Cached Medicine Technology:Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 2Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association 3Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 2Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment 3
(Date:9/16/2014)... September 17, 2014 Operation Smile was founded ... because of a facial deformity.” To spread their message and ... 19, 2014, at the Beverly Wilshire Hotel in Beverly Hills, ... people worldwide whose lives have been forever transformed by the ... be involved with Operation Smile,” said Lynda Erkiletian, Executive Director ...
(Date:9/16/2014)... CA (PRWEB) September 16, 2014 ... launch of two new product extensions, an accompanying ... headquarters, several novel marketing tools for their sales ... Vitamin Angels at their 5th annual national convention, ... room only crowd at the Hyatt Regency Orange ...
(Date:9/16/2014)... September 16, 2014 Pulmonary Hypertension Association Travels ... Education Forum for PH Patients and Families to Help Fight ... – the country’s leading pulmonary hypertension association that works to ... a disease of the lungs that affects the functioning of ... treatment, mean survivability is only 2.8 years. , What:, ...
(Date:9/16/2014)... Kathleen Doheny HealthDay ... A simple urine test can routinely spot human papillomavirus (HPV), ... new analysis found. "Our study shows that testing urine ... taken from the cervix for HPV," said lead researcher Dr. ... and research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Cliff Lake Dental ... team. Kristaleen is the newest dental hygienist to join Dr. ... forward to working with her and knows she will bring ... patients. , Kristaleen grew up in River Falls, WI. ... Technical College in 2003 and practiced dental assisting in the ...
Breaking Medicine News(10 mins):Health News:James & Paula Coburn Foundation to Host the 2014 Smile Gala, Presented by Operation Smile 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 2Health News:New Products Announced at Jusuru International’s R2E14 National Convention 3Health News:New Products Announced at Jusuru International’s R2E14 National Convention 4Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2
... Dec. 5 The American Society of,Hematology (ASH), ... recognize two United States Congressmen and a,hematologist for ... advocacy awards are given in conjunction with the ... Jackson (D-IL) and Edward Markey (D-MA) will both,receive ...
... December 5, 2007 Researchers in Montreal and ... the HIV/HAART*-associated Lipodystrophy Syndrome. This syndrome is a ... infection. Dr. Julian Falutz, Director of the HIV ... (MUHC), and Dr. Steven Grinspoon, Director at the ...
... efforts to reduce air pollution, especially diesel exhaust , , ... from Europe demonstrate the health damage done by automotive ... , An 11-year period of improving air quality in ... in Europe, produced measurable benefits in lung function for ...
... 5 Eastern Insurance,Holdings, Inc. (Nasdaq: EIHI ) ... has authorized a $0.05 per share quarterly cash,dividend on ... 28, 2007 to shareholders of record at the close ... parent company of Eastern Life and Health Insurance Company,("Eastern ...
... Dec. 5 Wyeth,Pharmaceuticals, a division of Wyeth ... been recognized for its leading scientific and pharmaceutical,achievements ... in London,England on December 4. Wyeth received honors ... awards are given out by Scrip World Pharmaceutical ...
... condition can be inherited from both parents, scientists say , ... spotted nine genetic markers that can increase a person,s risk ... can be inherited in what geneticists call a "recessive" manner ... identical copies of these markers from each parent, his or ...
Cached Medicine News:Health News:ASH Honors Two Congressmen and NIDDK Director for their Public Service and Leadership in Hematology 2Health News:Major breakthrough toward the treatment of HIV/HAART-associated Lipodystrophy Syndrome 2Health News:Cleaner Air Leads to Healthier Lungs 2Health News:Cleaner Air Leads to Healthier Lungs 3Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 2Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 2Health News:Wyeth Receives Honors at the 2007 Scrip Awards 3Health News:Wyeth Receives Honors at the 2007 Scrip Awards 4Health News:Wyeth Receives Honors at the 2007 Scrip Awards 5Health News:Genes Yield More Clues to Schizophrenia 2
... The Accutest H. pylori WB ... for the qualitative detection of ... pylori in human whole blood. ... as an aid in the ...
... Rapid 5 minutes immunoassay, based on ... a monoclonal antibody, for the qualitative ... human stool. The Premier Platinum HpSA, ... after extensive evaluation, was accepted as ...
Unitary one step immuno-chromatographic assay for the qualitative detection of infectious mononucleosis heterophile antibodies in human serum, plasma or whole blood....
The NOW® Flu B test is the most frequently adopted rapid flu test on the market today. Testing could not be easier and the results are available in 15 minutes. Now you can focus on the results an...
Medicine Products: